BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26719527)

  • 21. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
    Ramsey ML; Talbert E; Ahn D; Bekaii-Saab T; Badi N; Bloomston PM; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Farren MR; Hinton A; Krishna SG; Lesinski GB; Mace T; Manilchuk A; Noonan A; Pawlik TM; Rajasekera PV; Schmidt C; Guttridge D; Hart PA
    Pancreatology; 2019 Jan; 19(1):80-87. PubMed ID: 30497874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
    Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
    Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.
    Winnard PT; Bharti SK; Sharma RK; Krishnamachary B; Mironchik Y; Penet MF; Goggins MG; Maitra A; Kamel I; Horton KM; Jacobs MA; Bhujwalla ZM
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1487-1500. PubMed ID: 33006443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
    DeJong CH; Busquets S; Moses AG; Schrauwen P; Ross JA; Argiles JM; Fearon KC
    Oncol Rep; 2005 Jul; 14(1):257-63. PubMed ID: 15944798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling Human Cancer-induced Cachexia.
    Talbert EE; Cuitiño MC; Ladner KJ; Rajasekerea PV; Siebert M; Shakya R; Leone GW; Ostrowski MC; Paleo B; Weisleder N; Reiser PJ; Webb A; Timmers CD; Eiferman DS; Evans DC; Dillhoff ME; Schmidt CR; Guttridge DC
    Cell Rep; 2019 Aug; 28(6):1612-1622.e4. PubMed ID: 31390573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
    Jones-Bolin S; Ruggeri B
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice.
    Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
    Cancer Gene Ther; 2007 Dec; 14(12):945-52. PubMed ID: 17885675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
    Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
    Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia.
    Shukla SK; Dasgupta A; Mulder SE; Singh PK
    Methods Mol Biol; 2019; 1882():321-333. PubMed ID: 30378066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
    Asp ML; Tian M; Wendel AA; Belury MA
    Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models.
    Henderson SE; Makhijani N; Mace TA
    Pancreas; 2018 Sep; 47(8):937-945. PubMed ID: 30113428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
    Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
    Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia?
    van Royen M; Carbó N; Busquets S; Alvarez B; Quinn LS; López-Soriano FJ; Argilés JM
    Biochem Biophys Res Commun; 2000 Apr; 270(2):533-7. PubMed ID: 10753659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
    Markov SD; Gonzalez D; Mehla K
    Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
    Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
    Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
    Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
    Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.